Clinical Trial Update: A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL) [Phase 1, Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 1/2 trial evaluating romidepsin for peripheral T-cell lymphoma, including efficacy, safety, and pharmacokinetics,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Romidepsin (Istodax) (romidepsin)

Snippet

Sponsor: Celgene | Conditions: Lymphoma, T-cell, Peripheral | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-08-19